Literature DB >> 23587340

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Don Husereau1, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H Briggs, Josephine Mauskopf, Elizabeth Loder.   

Abstract

Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement is an attempt to consolidate and update previous health economic evaluation guidelines efforts into one current, useful reporting guidance. The primary audiences for the CHEERS statement are researchers reporting economic evaluations and the editors and peer reviewers assessing them for publication. The need for new reporting guidance was identified by a survey of medical editors. A list of possible items based on a systematic review was created. A two round, modified Delphi panel consisting of representatives from academia, clinical practice, industry, government, and the editorial community was conducted. Out of 44 candidate items, 24 items and accompanying recommendations were developed. The recommendations are contained in a user friendly, 24 item checklist. A copy of the statement, accompanying checklist, and this report can be found on the ISPOR Health Economic Evaluations Publication Guidelines Task Force website (www.ispor.org/TaskForces/EconomicPubGuidelines.asp). We hope CHEERS will lead to better reporting, and ultimately, better health decisions. To facilitate dissemination and uptake, the CHEERS statement is being co-published across 10 health economics and medical journals. We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years.

Mesh:

Year:  2013        PMID: 23587340     DOI: 10.1017/S0266462313000160

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  100 in total

Review 1.  Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review.

Authors:  Abedin Teimourizad; Aziz Rezapour; Saeed Sadeghian; Masih Tajdini
Journal:  Cost Eff Resour Alloc       Date:  2021-05-21

2.  Cost analysis of breast cancer diagnostic assessment programs.

Authors:  G N Honein-AbouHaidar; J S Hoch; M J Dobrow; T Stuart-McEwan; D R McCready; A R Gagliardi
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

Review 3.  Economic Evaluations of Mental Health Programs for Children and Adolescents in the United States: A Systematic Review.

Authors:  Jenna Y Sung; Corinne N Kacmarek; Jessica L Schleider
Journal:  Clin Child Fam Psychol Rev       Date:  2021-01-11

4.  Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review.

Authors:  Jie Fu; Yuchen Liu; Houwen Lin; Bin Wu
Journal:  Clin Drug Investig       Date:  2018-12       Impact factor: 2.859

5.  The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study.

Authors:  Blythe Adamson; Wafaa El-Sadr; Dobromir Dimitrov; Theresa Gamble; Geetha Beauchamp; Josh J Carlson; Louis Garrison; Deborah Donnell
Journal:  Value Health       Date:  2018-11-02       Impact factor: 5.725

6.  Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.

Authors:  Risa M Wolf; Roomasa Channa; Michael D Abramoff; Harold P Lehmann
Journal:  JAMA Ophthalmol       Date:  2020-10-01       Impact factor: 7.389

7.  The health care cost of palliative care for cancer patients: a systematic review.

Authors:  Sandhya Yadav; Isaac W Heller; Nancy Schaefer; Ramzi G Salloum; Sheri M Kittelson; Diana J Wilkie; Jinhai Huo
Journal:  Support Care Cancer       Date:  2020-05-21       Impact factor: 3.603

8.  Structured Pharmacist Review of Medication in Older Hospitalised Patients: A Cost-Effectiveness Analysis.

Authors:  James Gallagher; David O'Sullivan; Suzanne McCarthy; Paddy Gillespie; Noel Woods; Denis O'Mahony; Stephen Byrne
Journal:  Drugs Aging       Date:  2016-04       Impact factor: 3.923

9.  Siyaphambili protocol: An evaluation of randomized, nurse-led adaptive HIV treatment interventions for cisgender female sex workers living with HIV in Durban, South Africa.

Authors:  Carly A Comins; Sheree R Schwartz; Deliwe R Phetlhu; Vijayanand Guddera; Katherine Young; Jason E Farley; Nora West; Lauren Parmley; Elvin Geng; Chris Beyrer; David Dowdy; Sharmistha Mishra; Harry Hausler; Stefan Baral
Journal:  Res Nurs Health       Date:  2019-01-15       Impact factor: 2.228

10.  Exploratory cost-effectiveness analysis of 68Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer.

Authors:  Louisa G Gordon; Thomas M Elliott; Andre Joshi; Elizabeth D Williams; Ian Vela
Journal:  Clin Exp Metastasis       Date:  2020-02-17       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.